Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer [Phase 3]
Phase 3 trial evaluating endocrine therapy with or without abemaciclib (LY2835219) after breast cancer surgery has posted results and the st…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC [Phase 2]
Phase 2 neoadjuvant trial evaluating pembrolizumab with nab-paclitaxel followed by pembrolizumab with epirubicin/cyclophosphamide in triple-…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer [Phase 2]
Phase 2 study of chemotherapy followed by stem cell transplantation in patients with stage IIIB breast cancer has completed and results were…
-
FDA approval · 2021-04-02FDA Approved: LETROZOLE — Supplemental Application (Accord Healthcare, Inc.)
The FDA approved a supplemental application granting approval for Accord Healthcare, Inc.'s generic letrozole product.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of Azacitidine and Durvalumab in Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating azacitidine with durvalumab in advanced solid tumors has completed enrollment with conditions including microsatell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Radiation Therapy for ypN0 Breast Cancer [Phase 3]
A Phase 3 clinical trial update on radiation therapy for ypN0 breast cancer is listed, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab [Phase 2]
Phase 2 trial evaluating lisinopril or Coreg CR in reducing cardiac side effects in women with breast cancer receiving trastuzumab; study co…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Trastuzumab & Pertuzumab Followed by T-DM1 in MBC [Phase 2]
Phase 2 clinical trial exploring trastuzumab and pertuzumab followed by T-DM1 in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating safety and efficacy of everolimus (RAD001) in combination with letrozole for postmenopausal women with locally adva…
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer [Phase 2]
A Phase 2 pilot study evaluating safety and biological effects of orally administered reparixin in early breast cancer was terminated with r…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer [Phase 2]
Phase 2 trial update on T cell receptor immunotherapy targeting NY-ESO-1 in NY-ESO-1 expressing cancers; study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Decision-aid on Breast Cancer Screening [NA]
Clinical trial update on a decision-aid for breast cancer screening; study completed and results posted.
-
FDA approval · 2021-03-19FDA Approved: FULVESTRANT — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for fulvestrant by Sandoz Inc. under ANDA 205935, representing a supplemental approval for a gen…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Involving Family to Improve Communication in Breast Cancer Care [NA]
A completed clinical trial at Johns Hopkins investigated involving family members to improve communication in breast cancer care.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating elective internal mammary node irradiation in women with node-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant multi-agent chemotherapy or letrozole plus ribociclib in luminal B/HER2-negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer [Phase 3]
Phase 3 trial comparing docetaxel and ixabepilone in non-metastatic poor prognosis breast cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer [Phase 2]
Randomized Phase II study evaluating preoperative letrozole with Avastin in hormone receptor-positive breast cancer; trial terminated with p…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study [NA]
A completed patient intervention study addressing sexual concerns in breast cancer patients; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating an alternative dosing schedule of palbociclib in metastatic hormone receptor-positive breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk [Phase 2]
Phase II clinical trial investigating metformin for reducing obesity-associated breast cancer risk has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer [Phase 2]
Phase II trial of the CDK inhibitor PD 0332991 (palbociclib) in various adult solid tumors including colon and breast cancers has completed …
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery [Phase 4]
Phase 4 clinical trial evaluating Magseed magnetic marker for locating axillary lymph nodes in breast cancer patients undergoing surgery has…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment [Phase 4]
Phase 4 trial update evaluating polymorphisms and incidence of toxicity in eribulin treatment for metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating albumin-bound paclitaxel plus capecitabine versus capecitabine alone in paclitaxel/docetaxel-resistant advanced b…